#Donald Trump

Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.

The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.

A look at the 2019 State of the Union address

Four out of 10 FDA workers are sidelined.

Don’t delay! But be aware of these changes to the 2019 Affordable Care Act marketplace.

We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.

Legal experts claim the attack is “absurd.” But the Trump administration supports it.

A new law in Iowa allows “health benefit plans” that don’t meet federal insurance requirements.

Stocks of drug companies are rising—and that’s not a good sign for consumers.

A new law in Iowa allows “health benefit plans” that don’t meet federal insurance requirements.

A joint statement from the Infectious Diseases Society of America and the HIV Medicine Association to President Trump and Congress.

Brenda Fitzgerald faced other questions about conflicts of interest. Anne Schuchat has been named the CDC’s acting director.

A recent letter to the Trump administration signed by more than 60 advocacy organizations says yes.

That assertion is a “complete mischaracterization of discussions,” says an HHS spokesperson.

U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”

The president’s failure to declare the epidemic a “national emergency” means no additional funding will be released to address the issue...